This Article Full Text Free Full Text (PDF) Free All Versions of this Article: chest.06-2666v1 131/6/1710    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Regamey, N. Articles by Davies, J. C. Search for Related Content PubMed PubMed Citation Articles by Regamey, N. Articles by Davies, J. C. Related Content Related Editorial

Quality, Size, and Composition of Pediatric Endobronchial Biopsies in Cystic Fibrosis^*

^* From the Departments of Paediatric Respiratory Medicine (Drs. Regamey, Hilliard, Saglani, Balfour-Lynn, Rosenthal, Bush, and Davies), Lung Pathology (Drs. Zhu and Jeffery), and Anaesthesiology (Dr. Scallan), Royal Brompton Hospital, London, UK; and Department of Gene Therapy (Dr. Alton), National Heart and Lung Institute, Imperial College London, London, UK.

Correspondence to: Nicolas Regamey, MD, Department of Gene Therapy, National Heart and Lung Institute, Imperial College London, 1B Manresa Rd, London SW3 6LR, UK; e-mail: N.Regamey{at}imperial.ac.uk

Abstract

Background: Studies on airway remodeling in children with cystic fibrosis (CF) may be hampered by difficulty in obtaining evaluable endobronchial biopsy specimens because of large amounts of mucus and inflammation in the CF airway. We prospectively assessed how the quality of biopsy specimens obtained from children with CF compare with those from children with other airway diseases.

Methods: Fiberoptic bronchoscopy with endobronchial biopsy was performed in 67 CF children (age range, 0.2 to 16.8 years), 34 children with wheeze/asthma (W/A), and 64 control children with chronic respiratory symptoms. Up to three biopsy specimens were taken and stained with hematoxylin and eosin. Biopsy specimen size and structural composition were quantified using stereology.

Results: At least one evaluable biopsy specimen was obtained in 72% of CF children, in 79% of children with W/A, and in 72% of control subjects (difference was not significant). The use of large biopsy forceps (2.0 mm) rather than small biopsy forceps (1.0 mm) [odds ratio (OR), 5.8; 95% confidence interval (CI), 1.1 to 29.8; p = 0.037] and the number of biopsy specimens taken (odds ratio, 2.6; 95% confidence interval, 1.3 to 5.2; p = 0.006) significantly contributed to the success rate. Biopsy size and composition were similar between groups, except that CF children and those patients with W/A had a higher percentage of the biopsy specimen composed of muscle than did control subjects (median 6.2% and 9.7% vs 0.9%, respectively; p = 0.002).

Conclusions: Biopsy size and quality are adequate for the study of airway remodeling in CF children as young as 2 months of age. Researchers should use large forceps when possible and take at least two biopsy specimens per patient. An increased airway smooth muscle content of the airway mucosa may contribute to the pathophysiology of CF lung disease.

Key Words: airway remodeling • airway smooth muscle • biopsy • child • cystic fibrosis

Related Editorial

Endobronchial Biopsy in Childhood

Andrew A. Colin and Tarig Ali-Dinar
Chest 2007 131: 1626-1627. [Full Text] [PDF]

This article has been cited by other articles:

				N. Regamey, T. N. Hilliard, S. Saglani, J. Zhu, I. M. Balfour-Lynn, M. Rosenthal, P. K. Jeffery, E. W. F. W. Alton, A. Bush, J. C. Davies, et al. Endobronchial Biopsy in Childhood Chest, January 1, 2008; 133(1): 312 - 313. [Full Text] [PDF]